Nonmedication Devices in Development for the Treatment of Alzheimer's Disease

被引:0
|
作者
Sleem, Tamara [1 ]
Decourt, Boris [2 ]
Sabbagh, Marwan N. [1 ]
机构
[1] Barrow Neurol Inst, St Josephs Hosp & Med Ctr, Dept Neurol, Phoenix, AZ USA
[2] Texas Tech Univ Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; clinical trials; devices; treatment; DEEP BRAIN-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE-STIMULATION; COGNITIVE FUNCTION; SYNAPTIC PLASTICITY; CORTEX EXCITABILITY; DOUBLE-BLIND; PHOTOBIOMODULATION; CONNECTIVITY; DEMENTIA;
D O I
10.3233/ADR-230115
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huge investments continue to be made in treatment for Alzheimer's disease (AD), with more than one hundred drugs currently in development. Pharmacological approaches and drug development, particularly those targeting amyloid-beta, have dominated the therapeutic landscape. At the same time, there is also a growing interest in devices for treating AD. This review aimed to identify and describe devices under development for AD treatment. In this review, we queried the devices that are in development for the treatment of AD. PubMed was searched through the end of 2021 using the terms "device," "therapeutics," and "Alzheimer's" for articles that report on devices to treat AD. Ten devices with 31 references were identified as actively being developed for the treatment of AD. Many of these devices are far along in development. Device-based therapies are often overlooked when evaluating treatment approaches to AD. However, many devices for treating AD are in development and some show promising results.
引用
收藏
页码:241 / 255
页数:15
相关论文
共 50 条
  • [1] Non-pharmacological treatment of Alzheimer's disease: an update
    Wang, Shaofen
    Xu, Haochen
    Liu, Guangdong
    Chen, Limei
    FRONTIERS IN AGING NEUROSCIENCE, 2025, 17
  • [2] Brain stimulation for combating Alzheimer's disease
    Hansen, Niels
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [3] Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies
    Broadstock, Martin
    Ballard, Clive
    Corbett, Anne
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (13) : 1797 - 1810
  • [4] Treatment of epilepsy in patients with Alzheimer's disease
    Giorgi, Filippo Sean
    Guida, Melania
    Vergallo, Andrea
    Bonuccelli, Ubaldo
    Zaccara, Gaetano
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (03) : 309 - 318
  • [5] Updates on pharmacological treatment for Alzheimer's disease
    Tipton, Philip W.
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2024, 58 (02) : 150 - 160
  • [6] The Mechanism of Chemical and Physical Intervention on Prevention and Treatment of Alzheimer's Disease
    Pan Zhao-Tao
    Ma Yu-Tao
    Xiao Biao
    Lin Su-Yang
    Gao Jun-Yan
    Shan Jiang-Hui
    Chu Chao-Yang
    Shen Wei
    Xie Kai
    Li Li-Ping
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (10) : 2287 - 2304
  • [7] PROGRESS IN THE DEVELOPMENT OF NEW DRUGS IN ALZHEIMER'S DISEASE
    Piau, A.
    Nourhashemi, F.
    Hein, C.
    Caillaud, C.
    Vellas, B.
    JOURNAL OF NUTRITION HEALTH & AGING, 2011, 15 (01) : 45 - 57
  • [8] Treatment of Alzheimer's Disease and Future Approaches.
    Forette, Francoise
    Hauw, Jean-Jacques
    THERAPIE, 2010, 65 (05): : 429 - 437
  • [9] Effectiveness and Safety of Memantine Treatment for Alzheimer's Disease
    Yang, Zhendong
    Zhou, Xiangyu
    Zhang, Qi
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 36 (03) : 445 - 458
  • [10] The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer's Disease
    Penketh, Philip G.
    Shyam, Krishnamurthy
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2023, 13 (01):